Assessment of pharmacokinetic interaction of spirulina with glitazone in a type 2 diabetes rat model

Journal of Medicinal Food

Volumn 16, Issue 12, 2013, Pages 1095-1100

  Gupta, Annu ^a   Al Dhubiab, Bandar E ^b   Chattopadhyaya, Ipshita ^a   Nair, Anroop ^b   Kumria, Rachna ^a   Gupta, Sumeet ^a  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes mellitus; Pharmacokinetic; Pioglitazone; Rosiglitazone; Spirulina

Indexed keywords

INSULIN; PIOGLITAZONE; ROSIGLITAZONE; SPIRULINA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ANIMALS; DEXAMETHASONE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; RATS; RATS, WISTAR; SPIRULINA; THIAZOLIDINEDIONES;

EID: 84890528576     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2716     Document Type: Article

References (32)

1. Jayakumar RV: Herbal medicine for type 2 diabetes. Int J Diabetes Dev Ctries 2010;30: 111-112.
2. Satyanarayana T, Katyayani BM, Latha HE, Mathews AA, Chimna EM: Hypoglycemic & anti-hyperglycemic effect of alcoholic extract of euphoria leucophylla & its fraction in normal in alloxan induced diabetic rats. Pharmco Mag 2006;2: 244-253.
3. Malviya N, Jain S, Malviya S: Anti-diabetic potential of medicinal plants. Acta Pol Pharm Drug Res 2010;67: 113-118.
4. Singh IP, Bharate SB, Bhutani KK: Interactions of herbs & food products with drugs grape fruit juice as an example. Nat Prod Rad 2005;4: 107-112.
5. Letimann JM, Moore CB, Smith-Oliver TA, Wilkinson WO, Wilson TM: An anti diabetic thiazolidinedione is a highly affinity ligand for peroxisome proliferators activated receptor gamma (PPAR-gamma). J Biol Chem 1995;270: 12953-12956.
6. Lee CH, Olson P, Evans RM: Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptor. Endocrinology 2003;144: 2201-2207.
7. Rosen ED, Spiegelman BM: PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001; 276: 37731-37734.
8. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL: Inhibition of Osf2/Cbfa1/expression and terminal osteoblast differentiation by PPAR-gamma2. J Cell Biochem 1999;74: 357-371.
9. Hayashi K, Hayashi T, Kojima I: A natural sulfated polysaccharide, calcium spirulina isolated from Spirulina plantensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and antihuman immuno-deficiency virus activities. AIDS Res Hum Retroviruses 1996;12: 1463-1471.
10. Mittal A, Suresh-Kumar PV, Banerjee S, Rao AR, Kumar A: Modulatory potential of Spirulina fusiformis on carcinogen metabolizing enzymes in swiss albino mice. Phytother Res 1999;13: 111-114.
11. Qureshi MA, Garlich JD, Kidd MT: Dietary Spirulina plantesis enhances humoral and cell mediated immune functions in chickens. Immunopharmacol Immunotoxicol 1996;18: 465-476.
12. Simsek N, Karadeniz A, Kalkan Y, Keles ON, Unal B: Spirulina platensis feeding inhibited the anemia- and leucopeniainduced lead and cadmium in rats. J Hazard Mater 2009;164: 1304-1309.
13. Verma S, Samarth, R, Panwar M: Evaluation of radioprotective effects of Spirulina in Swiss albino mice. Asian J Exp Sci 2000; 20: 121-126.
14. Saxena PS, Kumar M: Modulatory potential of Spirulina fusiformis on testicular phosphatases in Swiss albino mice against mercury intoxication. Indian J Exp Biol 2004;42: 998-1002.
15. Jarouliya U, Zacharia JA, Kumar P, Bosen PS, Prasad GBKS: Alleviation of metabolic abnormalities induced by excessive fructose administration in wistar rats by Spirulina maxima. Indian J Med Res 2012;135: 422-428.
16. Gupta S, Hrishikeshvan HJ, Sehajpal PK: Spirulina protects against rosiglitazone induced osteoporosis in insulin resistance rats. Diabetes Res Clin Pract 2010;87: 38-43.
17. Chauhan D, Mehla K, Nair A, Sehajpal PK, Gupta S: Spirulina reverses histomorphological changes in diabetic osteoporosis in pioglitazone treated rats. J Diabetes Metab 2012;S1-S7
18. Karthik A, Subramanian G, Rao CM, Bhat K, Ranjithkumar A, Musmade P, Surulivelrajan M, Karthikeyan K, Udupa N: Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. Pak J Pharm Sci 2008;21: 421-425.
19. Bazargan M, Davey AK, Muhlhausler BS, Morrison JL, McMillen IC, Foster DJ: Simple HPLC method for determination of rosiglitazone in sheep plasma and amniotic fluid and its application in a pregnant sheep model. J Pharm Biomed Anal 2011;55: 360-365.
20. Razavi SH: UV-HPLC/APCI-MS method for separation and identification of the carotenoids produced by Sporobolomyces ruberrimus H110. Iran J Chem Chem Eng 2006;25: 1-10.
21. WHO: Global status report on noncommunicable diseases. 2010. http://whqlibdoc.who.int/publications/2011/978924068 6458-eng.pdf (last accessed on April 2011).
22. Ferrara A, Lewis JD, Quesenberry CP: Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care 2011;34: 923-929.
23. Lewis JD, Ferrara A, Peng T: Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011;34: 916-922.
24. Shalam MD, Harish MS, Farhana SA: Prevention of dexamethasone-and fructose-induced insulin resistance in rats by SH-01D, a herbal preparation. Indian J Pharmacol 2006;38: 419-422.
25. Turnbow MA, Keller SR, Rice M, Garner CW: Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L-1 adipocytes. J Biol Chem 1994;269: 2516-2520.
26. Kathryn MT, Charles KL, Claybunn R: Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005;289:E735-E745.
27. Seshadri CV, Umesh BV, Manoharan R: Beta-carotenestudies in Spirulina. Bioresour Technol 1991;38: 111-113.
28. Yeum KJ, Russell RM: Carotenoid bioavailability and bioconversion. Annu Rev Nutr 2002;22: 483-504.
29. Dasgupta T, Banerjee S, Yadav PK: Chemomodulation of carcinogen metabolizing enzymes, antioxidant profiles and skin and forestomach papillomagenesis by Spirulina platensis. Mol Cell Biochem 2001;226: 27-38.
30. Premkumar K, Pachiappan A, Abraham SK: Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 2001;72: 906-911.
31. Prasad N, Ravi Karan M, Kanwar JR: Influence of curcumin on pioglitazone metabolism and PK/PD: diabetes mellitus. J Diabetes Metab 2012: 2155-6156.
32. Premkumar K, Abraham, SK, Santhiya ST: Protective effect of Spirulina fusiformis on chemical-induced genotoxicity in mice. Fitoterapia 2004;75: 24-31.